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Dwith those who maintained a normal temperature (ie,
>36C). Greater degrees of hypothermia (ie,<34C vs
34C) did not result in more benefit. The strength of
our analysis was the large number of subjects in the
database. Additional examination of the data is indicated
to better identify the breakpoint temperature at which
benefit will be derived.
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hypothermic coronary bypass surgery. Lancet. 1994;343:559-63.MMENTARYTo cool or not to cool?Jennifer S. Lawton, MDTo cool or not to cool—that is the question that is raised by
the recent study by Greason and colleagues1 appearing in
this issue of the Journal. Greason and colleagues1 used
the Society of Thoracic Surgeons database to evaluate
patients undergoing nonemergency on-pump isolated
coronary artery bypass grafting (CABG) with specific
attention to the effect of lowest intraoperative recorded
core body temperature on the primary end point of operative
mortality and secondary end points of stroke, reoperation
for bleeding, and a combined infection end point.
The main strength of the study is in the large number of
patients included in the analysis (N ¼ 142,541), because
previous studies have had too few patients to demonstrate
meaningful statistical differences between groups. Patients
were categorized into temperature groups according to the
lowest recorded intraoperative temperature: moderate
hypothermia (34C; N ¼ 94,777), mild hypothermia
(>34C and 36C; N ¼ 42,750), and normothermia
(>36C; N¼ 5014). The study spanned an 18-month period.Univariate analysis demonstrated that mild hypothermia
was better than moderate hypothermia which in turn was
better than normothermia for the end point of operative
mortality; however, operative mortality was 1.5% in the
moderate hypothermia group, 1.3% in the mild hypother-
mia group, and 2.1% in the normothermia group. After
multivariate analysis, mild and moderate hypothermia
were protective relative to normothermia for the primary
end point of operative mortality; however, mild hypother-
mia was not protective relative to moderate hypothermia.
Unfortunately, this large study was retrospective in
nature and involved very different populations and
enrollment biases. Clearly, the normothermic group was
the sickest of all groups; it had more patients with lower
ejection fraction, diabetes mellitus, chronic lung disease,
recent myocardial infarction, unstable angina, higher New
York Heart Association classification, atrial fibrillation or
flutter, and urgent status. The normothermic patient group
also had a higher incidence of readmission to the intensive
care unit. In addition, Greason and colleagues1 excluded
patients with known predictors of operative mortality
(N ¼ 73,780), including reoperation, shock, emergency
status with resuscitation, or salvage, to ‘‘create study
cohorts that were as homogeneous as possible.’’ This may
have introduced additional bias, despite multivariate
adjustment attempts.
Do the results of this study indicate that hypothermia
is good, hyperthermia is bad, or both? Greason and
colleagues1 speculated that hypothermia is protective as a
result of reduced oxygen demand during CABG; however,
does this really affect operative mortality? Hypothermia




Dwith coagulopathy, altered oxygenator performance,
prolonged emergence from anesthesia, and delayed
drug metabolism after surgery.2,3 Interestingly, the
moderate hypothermia group in the study of Greason and
colleagues1 had a higher incidence of intraoperative and
postoperative blood transfusion, probably related to
coagulopathy. Conversely, hyperthermia is known to be
associated with increased risk of mediastinitis, altered
cerebral oxygen transfer, and, more importantly, acute
kidney injury, which is known predictor of poor outcome
after CABG.4-7 It is not possible to determine whether
this had a role in the observed differences in operative
mortality, because all postoperative complications,
including the incidence of acute kidney injury, were not
reported by Greason and colleagues.1
The results of the Greason study prompt the question,
‘‘Will cooling my patient just 1C more on pump reduce
my CABG operative mortality rate? If so, how low do
I go?’’ We as surgeons intuitively assume that reduced
oxygen consumption (systemic andmyocardial) is good—we
anecdotally ‘‘drift’’ on bypass to a certain temperature and
then often cool additional degrees to ‘‘protect the patient
and myocardium’’ if a case becomes more complicated and
lengthy intraoperatively. Knowing whether these maneuvers
are truly beneficial would be of practical benefit to patient
outcomes. Similarly, these maneuvers could be easily
achieved as we maintain complete control over patient tem-
perature during on-pump CABG.
To date, a few small randomized studies have concluded
that neurologic injury, leukodepletion, and the release of
inflammatory mediators during cardiopulmonary bypass
are independent of temperature.8-10 The study by Greason
and colleagues1 thus brings to light an important topic forThe Journal of Thoracic and Cara large prospective, randomized trial of intraoperative
temperature regulation with assessment of inflammatory
mediators, organ injury markers, and long-term outcomes
(including cause of death) after on-pump CABG. Until
such a trial is conducted, the clinical implications of the
reported findings remain unknown.
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